250 related articles for article (PubMed ID: 21486221)
1. Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.
Brooks J; Eltom SE
Curr Cancer Drug Targets; 2011 Jun; 11(5):654-69. PubMed ID: 21486221
[TBL] [Abstract][Full Text] [Related]
2. Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).
Wong PS; Li W; Vogel CF; Matsumura F
BMC Cancer; 2009 Jul; 9():234. PubMed ID: 19604390
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.
Goode GD; Ballard BR; Manning HC; Freeman ML; Kang Y; Eltom SE
Int J Cancer; 2013 Dec; 133(12):2769-80. PubMed ID: 23733406
[TBL] [Abstract][Full Text] [Related]
4. Interactive effects of inflammatory cytokine and abundant low-molecular-weight PAHs on inhibition of gap junctional intercellular communication, disruption of cell proliferation control, and the AhR-dependent transcription.
Kabátková M; Svobodová J; Pěnčíková K; Mohatad DS; Šmerdová L; Kozubík A; Machala M; Vondráček J
Toxicol Lett; 2015 Jan; 232(1):113-21. PubMed ID: 25268939
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
Vogel CFA; Lazennec G; Kado SY; Dahlem C; He Y; Castaneda A; Ishihara Y; Vogeley C; Rossi A; Haarmann-Stemmann T; Jugan J; Mori H; Borowsky AD; La Merrill MA; Sweeney C
Front Immunol; 2021; 12():625346. PubMed ID: 33763068
[TBL] [Abstract][Full Text] [Related]
6. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-fat diet and intestinal aryl hydrocarbon receptor deletion on colon carcinogenesis.
Garcia-Villatoro EL; DeLuca JAA; Callaway ES; Allred KF; Davidson LA; Hensel ME; Menon R; Ivanov I; Safe SH; Jayaraman A; Chapkin RS; Allred CD
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G451-G463. PubMed ID: 31905023
[TBL] [Abstract][Full Text] [Related]
8. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
9. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
10. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
[TBL] [Abstract][Full Text] [Related]
11. The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.
Dever DP; Opanashuk LA
Mol Pharmacol; 2012 May; 81(5):669-78. PubMed ID: 22311706
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
[TBL] [Abstract][Full Text] [Related]
13. Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer.
Goode G; Pratap S; Eltom SE
PLoS One; 2014; 9(6):e100103. PubMed ID: 24932473
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells.
Andrysík Z; Vondrácek J; Machala M; Krcmár P; Svihálková-Sindlerová L; Kranz A; Weiss C; Faust D; Kozubík A; Dietrich C
Mutat Res; 2007 Feb; 615(1-2):87-97. PubMed ID: 17141280
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene at human blood equivalent level induces human lung epithelial cell invasion and migration via aryl hydrocarbon receptor signaling.
Gao H; Ye G; Lin Y; Chi Y; Dong S
J Appl Toxicol; 2020 Aug; 40(8):1087-1098. PubMed ID: 32166782
[TBL] [Abstract][Full Text] [Related]
16. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis.
Trombino AF; Near RI; Matulka RA; Yang S; Hafer LJ; Toselli PA; Kim DW; Rogers AE; Sonenshein GE; Sherr DH
Breast Cancer Res Treat; 2000 Sep; 63(2):117-31. PubMed ID: 11097088
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
19. A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells.
Gearhart-Serna LM; Davis JB; Jolly MK; Jayasundara N; Sauer SJ; Di Giulio RT; Devi GR
Carcinogenesis; 2020 Dec; 41(12):1648-1659. PubMed ID: 32747956
[TBL] [Abstract][Full Text] [Related]
20. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
